No one can win the fight against rare disease on their own. EFPIA reaffirms our industry’s commitment to working with all parts of the eco-system to tackle the burden of rare diseases.
More information about the Rare Disease Day is available here.
Read more
A change to European rules on drug manufacturing that could benefit makers of generics and biosimilars is edging closer,...
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.